BTG’s varicose-vein drug successful in U.S. study

LONDON (Reuters) – British pharmaceutical firm BTG said the first of two U.S. trials of its varicose vein treatment Varisolve had met all its end-points, bringing a launch of the long-delayed product a step closer. Varisolve is a ground-breaking t…

View full post on Yahoo! Health News

, , , , ,

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Get Adobe Flash player

Powered by Yahoo! Answers

© 1992-2012 DC2NET™, Inc. All Rights Reserved